Michael Mitgang

Michael Mitgang is an accomplished investor and operator with over 20 years of experience in the technology and legal cannabis sectors. He is the founder and Managing Director of WGD Capital/WGD Partners, a firm that invests in early- and expansion-stage private companies in the USA, Canada, and Israel, focusing on the health and wellness market, particularly in the legal cannabis and psychedelic industries.1

Key aspects of Michael Mitgang's background and expertise include:

Professional Experience

• Over 20 years in technology and legal cannabis sectors
• Former head of Private Placements at Piper Jaffray
• Investment banker at Salomon Smith Barney and BMO Nesbitt
• Expertise in deal origination, valuation, structuring, due diligence, and closing transactions

Education

• MBA from Columbia University's Columbia Business School
• BASc from the University of Waterloo

Investment Focus

Mitgang's firm, WGD Capital, invests in companies across various sectors, including:

• Cannabis
• Psychedelics
• Ag-tech
• Health and wellness industries

Involvement with Lykos Therapeutics

Mitgang is an investor in Lykos Therapeutics (formerly MAPS PBC), a company focused on treating mental health conditions with psychedelic-assisted therapies.1 Recently, he shared exciting news about Lykos Therapeutics:

• FDA acceptance of their New Drug Application for MDMA-Assisted Therapy for PTSD2
• Priority Review status granted by the FDA for their New Drug Application for patients with PTSD3

Additional Interests

Beyond his professional accomplishments, Mitgang is:

• An accomplished sailor who completed a 28-month, 14,000 nautical mile cruise with his family across the Pacific Ocean
• An active mountain biker and yogi

Michael Mitgang's LinkedIn username is mmitgang, as mentioned in the query.